PCH
DCPH

Polar Capital Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Polar Capital Holdings’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,500,000
Closed -$23.6M – 302
2024
Q1 		$23.6M Sell
1,500,000
-350,000
-19% -$5.39M 0.12% 136
2023
Q4 		$29.8M Buy
1,850,000
+100,000
+6% +$1.28M 0.18% 110
2023
Q3 		$22.3M Hold
1,750,000
– – 0.17% 134
2023
Q2 		$24.6M Hold
1,750,000
– – 0.12% 131
2023
Q1 		$27M Buy
1,750,000
+500,000
+40% +$8.35M 0.18% 121
2022
Q4 		$20.5M Hold
1,250,000
– – 0.16% 145
2022
Q3 		$23.1M Sell
1,250,000
-250,000
-17% -$3.92M 0.15% 130
2022
Q2 		$19.7M Buy
+1,500,000
New +$16.6M 0.12% 147
2022
Q1 		– Sell
-163,100
Closed -$1.59M – 491
2021
Q4 		$1.59M Sell
163,100
-400,000
-71% -$7.52M 0.01% 308
2021
Q3 		$19.1M Buy
563,100
+163,100
+41% +$5.21M 0.08% 176
2021
Q2 		$14.6M Hold
400,000
– – 0.06% 199
2021
Q1 		$17.9M Buy
400,000
+50,000
+14% +$2.33M 0.11% 167
2020
Q4 		$20M Buy
+350,000
New +$20.7M 0.12% 160

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Polar Capital Holdings's DCPH Position: Q2 2024 in Review

Polar Capital Holdings sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,500,000 shares — an estimated $23.6M sold.

Polar Capital Holdings first reported a position in DCPH in Q4 2020 and held it in 13 quarters. The position peaked at $29.8M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Polar Capital Holdings reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Polar Capital Holdings sold 1,500,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $23.6M.
  • Polar Capital Holdings first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • Polar Capital Holdings's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $29.8M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Polar Capital Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.